Science Corp., a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a ...

When Neal Piper’s son, Noah, rang the bell at UVA Children’s Hospital in December 2020, it signaled the end of grueling chemotherapy treatments connected to beeping monitors and intravenous tubes.

Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...

Annual Series B funding is moving steadily higher after hitting a low in 2023, Crunchbase data shows, and this year is off to a strong start as well.

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.

As venture funding becomes more selective, thoughtful decision-making and careful use of capital are becoming advantages in the startup landscape, especially for companies centered around life ...

Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into treatments for Alzheimer’s disease and expand into immune diseases. The Series B was led by Korean ...

Sonas Pharma closes pre-seed round backed by SFC Capital and Clarendon Fund Managers ...

Astellas Pharma will be inviting Japanese biotech startups to use its R&D lab as part of a government-backed acceleration program to help these companies “go global.” Participating drug discovery ...